Revolution Medicines, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.18 USD
−600.09 M USD
0.00 USD
165.30 M
About Revolution Medicines, Inc.
Sector
Industry
CEO
Mark A. Goldsmith
Website
Headquarters
Redwood City
Founded
2004
Identifiers
3
ISIN US76155X1182
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Displays a symbol's price movements over previous years to identify recurring trends.